0001437749-22-023060.txt : 20220926
0001437749-22-023060.hdr.sgml : 20220926
20220926160745
ACCESSION NUMBER: 0001437749-22-023060
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220923
FILED AS OF DATE: 20220926
DATE AS OF CHANGE: 20220926
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROGERS MICHAEL W
CENTRAL INDEX KEY: 0001244159
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36361
FILM NUMBER: 221265758
MAIL ADDRESS:
STREET 1: C/O KERYX BIOPHARMACEUTICALS INC
STREET 2: ONE MARINA PARK DRIVE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aravive, Inc.
CENTRAL INDEX KEY: 0001513818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264106690
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: RIVER OAKS TOWER
STREET 2: 3730 KIRBY DRIVE, SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
BUSINESS PHONE: 936-355-1910
MAIL ADDRESS:
STREET 1: RIVER OAKS TOWER
STREET 2: 3730 KIRBY DRIVE, SUITE 1200
CITY: HOUSTON
STATE: TX
ZIP: 77098
FORMER COMPANY:
FORMER CONFORMED NAME: Versartis, Inc.
DATE OF NAME CHANGE: 20110223
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-09-23
0001513818
Aravive, Inc.
ARAV
0001244159
ROGERS MICHAEL W
C/O ARAVIVE, INC., RIVER OAKS TOWER,
3730 KIRBY DRIVE, SUITE 1200
HOUSTON
TX
77098
1
Stock Option (Right to Buy)
0.9152
2022-09-23
4
A
0
97063
0
A
2022-10-23
2032-09-22
Common Stock
97063
97063
D
These options vest pro rata on a monthly basis commencing on October 23,2022 for the next 12 months with full vesting, if not fully vested at such time, on the date of Aravive, Inc.'s next annual meeting of stockholders.
/s/ Abel Svitavsky, Attorney-In-Fact
2022-09-26